Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoglycemia | 31 | 2024 | 883 | 10.190 |
Why?
|
Gastric Bypass | 31 | 2024 | 818 | 6.940 |
Why?
|
Bariatric Surgery | 23 | 2024 | 991 | 4.970 |
Why?
|
Obesity, Morbid | 20 | 2024 | 1278 | 2.640 |
Why?
|
Insulin Resistance | 33 | 2024 | 3952 | 2.410 |
Why?
|
Insulin | 45 | 2023 | 6588 | 2.390 |
Why?
|
Insulinoma | 4 | 2023 | 121 | 2.270 |
Why?
|
Obesity | 42 | 2024 | 12940 | 2.100 |
Why?
|
Diabetes Mellitus, Type 2 | 44 | 2024 | 12159 | 2.040 |
Why?
|
Glucagon | 7 | 2024 | 531 | 1.710 |
Why?
|
Blood Glucose | 39 | 2024 | 6392 | 1.670 |
Why?
|
Glucose | 17 | 2022 | 4342 | 1.370 |
Why?
|
Glucose Intolerance | 10 | 2016 | 575 | 1.360 |
Why?
|
Blood Glucose Self-Monitoring | 7 | 2023 | 468 | 1.310 |
Why?
|
Receptor, Insulin | 12 | 2016 | 836 | 1.160 |
Why?
|
Fibroblast Growth Factors | 5 | 2022 | 863 | 1.150 |
Why?
|
Adipose Tissue, Brown | 5 | 2023 | 766 | 1.150 |
Why?
|
Liver | 19 | 2021 | 7512 | 1.100 |
Why?
|
Bile Acids and Salts | 6 | 2017 | 394 | 1.090 |
Why?
|
Postprandial Period | 3 | 2024 | 314 | 1.050 |
Why?
|
Energy Metabolism | 13 | 2019 | 2877 | 0.970 |
Why?
|
Gastrectomy | 8 | 2024 | 672 | 0.960 |
Why?
|
Muscle, Skeletal | 19 | 2020 | 4947 | 0.950 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2024 | 3417 | 0.910 |
Why?
|
Insulin Antagonists | 1 | 2023 | 17 | 0.890 |
Why?
|
Nutrition Therapy | 2 | 2022 | 102 | 0.870 |
Why?
|
Malnutrition | 7 | 2017 | 622 | 0.850 |
Why?
|
Islets of Langerhans | 9 | 2014 | 1342 | 0.850 |
Why?
|
Insulin-Secreting Cells | 5 | 2017 | 898 | 0.830 |
Why?
|
Bariatrics | 1 | 2023 | 36 | 0.830 |
Why?
|
Hyperinsulinism | 4 | 2016 | 400 | 0.820 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2022 | 41 | 0.800 |
Why?
|
Metabolic Diseases | 4 | 2019 | 680 | 0.790 |
Why?
|
Receptors, Glucagon | 2 | 2014 | 90 | 0.790 |
Why?
|
Mitochondria, Muscle | 2 | 2017 | 172 | 0.780 |
Why?
|
Gene Expression Regulation | 17 | 2021 | 11855 | 0.780 |
Why?
|
Adipocytes | 10 | 2022 | 1190 | 0.770 |
Why?
|
Anti-Obesity Agents | 2 | 2023 | 227 | 0.750 |
Why?
|
Prenatal Exposure Delayed Effects | 9 | 2019 | 2517 | 0.730 |
Why?
|
Weight Loss | 6 | 2024 | 2680 | 0.720 |
Why?
|
Human Growth Hormone | 2 | 2022 | 642 | 0.710 |
Why?
|
Lipid Metabolism | 10 | 2019 | 1893 | 0.690 |
Why?
|
Birth Weight | 9 | 2019 | 2104 | 0.690 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5366 | 0.690 |
Why?
|
Serotonin | 1 | 2024 | 1042 | 0.670 |
Why?
|
AMP-Activated Protein Kinases | 4 | 2021 | 597 | 0.660 |
Why?
|
Metabolism | 2 | 2020 | 193 | 0.650 |
Why?
|
Hypoglycemic Agents | 12 | 2024 | 3089 | 0.650 |
Why?
|
Metabolome | 4 | 2021 | 989 | 0.640 |
Why?
|
Epigenesis, Genetic | 8 | 2022 | 3788 | 0.640 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2019 | 89 | 0.630 |
Why?
|
Incretins | 3 | 2022 | 99 | 0.590 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2023 | 1249 | 0.580 |
Why?
|
Postoperative Complications | 9 | 2024 | 15637 | 0.570 |
Why?
|
Muscle Fibers, Skeletal | 6 | 2016 | 543 | 0.570 |
Why?
|
Oxidative Phosphorylation | 4 | 2010 | 495 | 0.570 |
Why?
|
Adipocytes, White | 1 | 2018 | 91 | 0.570 |
Why?
|
Metabolomics | 4 | 2024 | 1658 | 0.540 |
Why?
|
Alanine | 2 | 2018 | 608 | 0.530 |
Why?
|
Humans | 131 | 2024 | 761222 | 0.520 |
Why?
|
Growth | 3 | 2009 | 366 | 0.510 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2016 | 1852 | 0.500 |
Why?
|
Fatty Liver | 5 | 2019 | 789 | 0.490 |
Why?
|
Gastrointestinal Agents | 1 | 2020 | 509 | 0.490 |
Why?
|
Animals | 73 | 2024 | 168089 | 0.490 |
Why?
|
Umbilical Cord | 1 | 2016 | 178 | 0.490 |
Why?
|
Iodide Peroxidase | 6 | 2015 | 294 | 0.470 |
Why?
|
Proteome | 2 | 2021 | 1856 | 0.470 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2016 | 390 | 0.460 |
Why?
|
Triiodothyronine | 4 | 2011 | 492 | 0.450 |
Why?
|
Mice, Inbred ICR | 8 | 2017 | 363 | 0.440 |
Why?
|
Hyperglycemia | 1 | 2022 | 1375 | 0.430 |
Why?
|
Lipogenesis | 3 | 2011 | 214 | 0.420 |
Why?
|
Fatty Acids, Nonesterified | 3 | 2015 | 392 | 0.420 |
Why?
|
Fasting | 6 | 2021 | 1603 | 0.420 |
Why?
|
Pregnancy Complications | 4 | 2016 | 2949 | 0.420 |
Why?
|
Terminology as Topic | 1 | 2020 | 1528 | 0.420 |
Why?
|
Mice | 48 | 2024 | 81330 | 0.420 |
Why?
|
Mitochondria | 4 | 2016 | 3620 | 0.420 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5783 | 0.410 |
Why?
|
Intestines | 2 | 2019 | 1908 | 0.410 |
Why?
|
Family Characteristics | 1 | 2017 | 992 | 0.390 |
Why?
|
Mothers | 3 | 2019 | 2193 | 0.390 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 20 | 0.390 |
Why?
|
Biosensing Techniques | 3 | 2022 | 647 | 0.380 |
Why?
|
DNA Methylation | 6 | 2019 | 4384 | 0.380 |
Why?
|
Male | 80 | 2024 | 360703 | 0.370 |
Why?
|
Serum Response Factor | 1 | 2011 | 78 | 0.370 |
Why?
|
Amino Acids | 5 | 2018 | 1703 | 0.360 |
Why?
|
Adipose Tissue | 6 | 2022 | 3313 | 0.360 |
Why?
|
Female | 78 | 2024 | 392552 | 0.350 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2024 | 0.350 |
Why?
|
Palmitic Acid | 2 | 2008 | 149 | 0.340 |
Why?
|
Palmitates | 1 | 2009 | 70 | 0.330 |
Why?
|
Endocannabinoids | 1 | 2010 | 111 | 0.330 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2010 | 137 | 0.330 |
Why?
|
Eating | 2 | 2007 | 1535 | 0.330 |
Why?
|
Insulin Receptor Substrate Proteins | 9 | 2013 | 557 | 0.320 |
Why?
|
Prediabetic State | 4 | 2018 | 546 | 0.320 |
Why?
|
Signal Transduction | 18 | 2021 | 23419 | 0.320 |
Why?
|
Fetal Growth Retardation | 3 | 2008 | 580 | 0.320 |
Why?
|
Thyroid Hormones | 2 | 2010 | 402 | 0.320 |
Why?
|
Pregnancy | 21 | 2023 | 29893 | 0.320 |
Why?
|
Animals, Newborn | 4 | 2011 | 2665 | 0.310 |
Why?
|
Infant, Low Birth Weight | 3 | 2014 | 869 | 0.310 |
Why?
|
Antigens, CD | 2 | 2016 | 4009 | 0.300 |
Why?
|
Body Mass Index | 13 | 2024 | 12952 | 0.300 |
Why?
|
Fetal Blood | 1 | 2015 | 1348 | 0.300 |
Why?
|
Carbohydrate Metabolism | 3 | 2018 | 262 | 0.300 |
Why?
|
Gastrointestinal Hormones | 2 | 2019 | 101 | 0.300 |
Why?
|
Nerve Tissue Proteins | 3 | 2011 | 4404 | 0.290 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 680 | 0.290 |
Why?
|
E2F4 Transcription Factor | 2 | 2006 | 32 | 0.280 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2008 | 199 | 0.280 |
Why?
|
Trans-Activators | 2 | 2009 | 2846 | 0.280 |
Why?
|
Betaine | 2 | 2018 | 90 | 0.280 |
Why?
|
Transcription Factors | 9 | 2022 | 12101 | 0.280 |
Why?
|
Fatty Acids | 2 | 2008 | 1807 | 0.270 |
Why?
|
Adult | 43 | 2024 | 221120 | 0.270 |
Why?
|
Glucagon-Like Peptide 1 | 3 | 2019 | 364 | 0.260 |
Why?
|
Dyslipidemias | 1 | 2013 | 870 | 0.260 |
Why?
|
Phosphoproteins | 8 | 2002 | 2444 | 0.260 |
Why?
|
Lipids | 3 | 2019 | 3331 | 0.250 |
Why?
|
Middle Aged | 38 | 2024 | 220858 | 0.250 |
Why?
|
Peptide Fragments | 2 | 2019 | 5103 | 0.250 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2011 | 1116 | 0.250 |
Why?
|
Triglycerides | 5 | 2014 | 2457 | 0.250 |
Why?
|
Diet, Reducing | 2 | 2006 | 485 | 0.250 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 2 | 2007 | 61 | 0.250 |
Why?
|
Energy Intake | 3 | 2017 | 2133 | 0.240 |
Why?
|
Cell Survival | 1 | 2015 | 5778 | 0.240 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 160 | 0.240 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2024 | 126 | 0.240 |
Why?
|
Dietary Fats | 6 | 2017 | 1994 | 0.240 |
Why?
|
Dietary Carbohydrates | 2 | 2017 | 891 | 0.230 |
Why?
|
Glucosamine | 2 | 2007 | 128 | 0.230 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1645 | 0.230 |
Why?
|
Muscles | 2 | 2006 | 1568 | 0.230 |
Why?
|
Cell Proliferation | 2 | 2017 | 10423 | 0.230 |
Why?
|
Thiazolidinediones | 2 | 2008 | 460 | 0.220 |
Why?
|
Carrier Proteins | 4 | 2021 | 4935 | 0.220 |
Why?
|
Growth Hormone | 2 | 2024 | 569 | 0.220 |
Why?
|
Glucose Tolerance Test | 4 | 2015 | 1178 | 0.220 |
Why?
|
Gastroplasty | 2 | 2019 | 157 | 0.220 |
Why?
|
Mice, Inbred C57BL | 16 | 2021 | 22128 | 0.220 |
Why?
|
Disease Susceptibility | 2 | 2008 | 1791 | 0.220 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2024 | 1933 | 0.210 |
Why?
|
Laparoscopy | 3 | 2019 | 2035 | 0.210 |
Why?
|
Gastric Inhibitory Polypeptide | 2 | 2017 | 68 | 0.210 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2012 | 3596 | 0.210 |
Why?
|
Spermatozoa | 2 | 2019 | 630 | 0.210 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1855 | 0.200 |
Why?
|
Postoperative Period | 2 | 2019 | 1818 | 0.200 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 153 | 0.200 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.200 |
Why?
|
Primary Dysautonomias | 1 | 2022 | 28 | 0.200 |
Why?
|
Adipogenesis | 2 | 2023 | 368 | 0.200 |
Why?
|
Ribosomal Protein S6 Kinases | 3 | 1999 | 203 | 0.190 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 68 | 0.190 |
Why?
|
Endocrine System Diseases | 1 | 2024 | 249 | 0.190 |
Why?
|
Islets of Langerhans Transplantation | 4 | 2014 | 743 | 0.190 |
Why?
|
Rodentia | 1 | 2023 | 261 | 0.190 |
Why?
|
Enzyme Activation | 6 | 2008 | 3577 | 0.190 |
Why?
|
Up-Regulation | 4 | 2019 | 4111 | 0.180 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 974 | 0.180 |
Why?
|
Immunoassay | 4 | 2022 | 743 | 0.180 |
Why?
|
Models, Animal | 4 | 2013 | 2114 | 0.180 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2020 | 11 | 0.180 |
Why?
|
Diabetes Mellitus | 5 | 2018 | 5842 | 0.180 |
Why?
|
Stem Cells | 2 | 2011 | 3517 | 0.170 |
Why?
|
Adiposity | 4 | 2019 | 1879 | 0.170 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 1480 | 0.170 |
Why?
|
Quality of Life | 3 | 2022 | 13367 | 0.170 |
Why?
|
Risk Factors | 15 | 2021 | 74241 | 0.170 |
Why?
|
Food | 2 | 2007 | 768 | 0.170 |
Why?
|
Adiponectin | 6 | 2024 | 1107 | 0.170 |
Why?
|
Gene Expression Profiling | 10 | 2022 | 9417 | 0.170 |
Why?
|
Hexosamines | 1 | 1999 | 38 | 0.170 |
Why?
|
Wound Healing | 1 | 2011 | 2800 | 0.170 |
Why?
|
Fructose | 1 | 2001 | 285 | 0.170 |
Why?
|
Mice, Knockout | 13 | 2021 | 14392 | 0.160 |
Why?
|
Paternal Exposure | 1 | 2019 | 96 | 0.160 |
Why?
|
Needles | 1 | 2022 | 453 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2008 | 2864 | 0.160 |
Why?
|
Feeding Behavior | 3 | 2017 | 3183 | 0.160 |
Why?
|
Paternal Behavior | 1 | 2018 | 33 | 0.160 |
Why?
|
Gene Expression | 5 | 2010 | 7571 | 0.160 |
Why?
|
Diglycerides | 1 | 2019 | 176 | 0.160 |
Why?
|
Rats | 9 | 2021 | 23705 | 0.150 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 593 | 0.150 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 1999 | 2897 | 0.150 |
Why?
|
Intermittent Claudication | 1 | 2020 | 304 | 0.150 |
Why?
|
Ketones | 1 | 2019 | 182 | 0.150 |
Why?
|
Hepatocytes | 2 | 2021 | 1230 | 0.150 |
Why?
|
Phosphorylation | 7 | 2011 | 8300 | 0.140 |
Why?
|
Hep G2 Cells | 1 | 2018 | 374 | 0.140 |
Why?
|
C-Peptide | 3 | 2024 | 442 | 0.140 |
Why?
|
Clinical Alarms | 1 | 2017 | 61 | 0.140 |
Why?
|
Mitochondrial Size | 1 | 2016 | 8 | 0.130 |
Why?
|
DNA, Mitochondrial | 2 | 2015 | 865 | 0.130 |
Why?
|
Cells, Cultured | 11 | 2021 | 18927 | 0.130 |
Why?
|
Citrate (si)-Synthase | 1 | 2016 | 48 | 0.130 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2019 | 629 | 0.130 |
Why?
|
Fathers | 1 | 2019 | 375 | 0.130 |
Why?
|
Case-Control Studies | 6 | 2020 | 22174 | 0.130 |
Why?
|
Metformin | 1 | 2024 | 910 | 0.130 |
Why?
|
Drug Monitoring | 1 | 2022 | 961 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2024 | 10218 | 0.130 |
Why?
|
Nutritional Status | 3 | 2024 | 1597 | 0.130 |
Why?
|
Pancreas | 2 | 2017 | 1684 | 0.130 |
Why?
|
Appetite | 1 | 2017 | 247 | 0.120 |
Why?
|
Cell Line | 4 | 2018 | 15545 | 0.120 |
Why?
|
Minerals | 1 | 2017 | 281 | 0.120 |
Why?
|
Antibodies | 1 | 2023 | 2415 | 0.120 |
Why?
|
Caloric Restriction | 2 | 2014 | 299 | 0.120 |
Why?
|
Epigenomics | 2 | 2018 | 944 | 0.120 |
Why?
|
Physical Conditioning, Animal | 1 | 2018 | 366 | 0.120 |
Why?
|
Fetal Nutrition Disorders | 1 | 2014 | 8 | 0.120 |
Why?
|
Sirolimus | 2 | 2019 | 1540 | 0.120 |
Why?
|
Inheritance Patterns | 1 | 2017 | 341 | 0.120 |
Why?
|
Vagus Nerve | 1 | 2017 | 458 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18222 | 0.120 |
Why?
|
Infant | 7 | 2019 | 36170 | 0.120 |
Why?
|
Glucagon-Secreting Cells | 1 | 2014 | 42 | 0.120 |
Why?
|
Citric Acid Cycle | 2 | 2007 | 231 | 0.110 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9567 | 0.110 |
Why?
|
Blood Proteins | 1 | 2019 | 1173 | 0.110 |
Why?
|
Arginine | 2 | 2014 | 920 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2082 | 0.110 |
Why?
|
Taurine | 1 | 2014 | 92 | 0.110 |
Why?
|
Placenta | 2 | 2021 | 1711 | 0.110 |
Why?
|
Dumping Syndrome | 2 | 2019 | 18 | 0.110 |
Why?
|
Infant, Newborn | 6 | 2019 | 26200 | 0.110 |
Why?
|
Absorptiometry, Photon | 2 | 2011 | 1738 | 0.100 |
Why?
|
Oxidation-Reduction | 2 | 2009 | 2227 | 0.100 |
Why?
|
Cell Lineage | 1 | 2022 | 2549 | 0.100 |
Why?
|
Body Weight | 3 | 2013 | 4618 | 0.100 |
Why?
|
Cohort Studies | 6 | 2016 | 41496 | 0.100 |
Why?
|
Caffeine | 1 | 2017 | 701 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 1988 | 0.100 |
Why?
|
Down-Regulation | 2 | 2016 | 2916 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2293 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1889 | 0.100 |
Why?
|
Dietary Proteins | 1 | 2017 | 951 | 0.100 |
Why?
|
Thyroid Diseases | 1 | 2015 | 386 | 0.090 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 609 | 0.090 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 2011 | 35 | 0.090 |
Why?
|
Protein Kinase C-delta | 1 | 2011 | 114 | 0.090 |
Why?
|
Fetal Development | 1 | 2016 | 768 | 0.090 |
Why?
|
Hypercholesterolemia | 1 | 2018 | 1141 | 0.090 |
Why?
|
Exercise | 3 | 2021 | 5874 | 0.090 |
Why?
|
Leptin | 3 | 2014 | 1595 | 0.090 |
Why?
|
Lactic Acid | 1 | 2016 | 1139 | 0.090 |
Why?
|
PPAR gamma | 3 | 2008 | 483 | 0.090 |
Why?
|
Phenylbutyrates | 1 | 2011 | 72 | 0.090 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15521 | 0.090 |
Why?
|
Thyroid Hormone Receptors beta | 1 | 2010 | 21 | 0.090 |
Why?
|
Reward | 1 | 2017 | 968 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2452 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2024 | 80675 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1468 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2012 | 323 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2803 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1122 | 0.090 |
Why?
|
Mice, Inbred NOD | 2 | 2007 | 1822 | 0.090 |
Why?
|
Aged | 12 | 2024 | 169292 | 0.090 |
Why?
|
Appetite Regulation | 1 | 2010 | 84 | 0.090 |
Why?
|
Pyrazines | 1 | 2015 | 1202 | 0.080 |
Why?
|
Dietary Supplements | 3 | 2018 | 3410 | 0.080 |
Why?
|
Autoradiography | 1 | 2010 | 730 | 0.080 |
Why?
|
Oxidative Stress | 3 | 2017 | 3114 | 0.080 |
Why?
|
Midline Thalamic Nuclei | 1 | 2009 | 14 | 0.080 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2009 | 37 | 0.080 |
Why?
|
Cell Size | 2 | 2009 | 625 | 0.080 |
Why?
|
Algorithms | 3 | 2020 | 14025 | 0.080 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2009 | 72 | 0.080 |
Why?
|
Muscle Development | 1 | 2011 | 258 | 0.080 |
Why?
|
Phenotype | 3 | 2017 | 16575 | 0.080 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1275 | 0.080 |
Why?
|
Triazenes | 1 | 2008 | 8 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2016 | 794 | 0.080 |
Why?
|
CpG Islands | 1 | 2013 | 1190 | 0.080 |
Why?
|
Organ Size | 2 | 2011 | 2253 | 0.080 |
Why?
|
Bone Marrow | 1 | 2019 | 2911 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2010 | 3777 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2020 | 12341 | 0.080 |
Why?
|
Mesangial Cells | 1 | 2008 | 23 | 0.080 |
Why?
|
Acetates | 1 | 2010 | 319 | 0.080 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2317 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2005 | 1651 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4310 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1634 | 0.080 |
Why?
|
Hyperphagia | 1 | 2009 | 139 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2024 | 64681 | 0.080 |
Why?
|
Genome | 1 | 2016 | 1738 | 0.080 |
Why?
|
Confusion | 1 | 2010 | 278 | 0.080 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2008 | 85 | 0.080 |
Why?
|
Ribonucleotides | 1 | 2008 | 114 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1176 | 0.080 |
Why?
|
Epoxy Compounds | 1 | 2008 | 137 | 0.080 |
Why?
|
RNA, Messenger | 6 | 2011 | 12747 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2138 | 0.070 |
Why?
|
Receptors, Leptin | 1 | 2009 | 350 | 0.070 |
Why?
|
STAT5 Transcription Factor | 1 | 2008 | 266 | 0.070 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 178 | 0.070 |
Why?
|
Syncope | 1 | 2010 | 428 | 0.070 |
Why?
|
Haplotypes | 1 | 2013 | 2715 | 0.070 |
Why?
|
GRB2 Adaptor Protein | 2 | 1998 | 101 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2011 | 9520 | 0.070 |
Why?
|
Cell Differentiation | 5 | 2023 | 11512 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1831 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2002 | 2871 | 0.070 |
Why?
|
RNA Splicing | 1 | 2011 | 896 | 0.070 |
Why?
|
Homeostasis | 4 | 2016 | 3322 | 0.070 |
Why?
|
Zinc Fingers | 1 | 2009 | 575 | 0.070 |
Why?
|
Angiotensins | 1 | 2007 | 141 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2008 | 412 | 0.070 |
Why?
|
Weight Gain | 2 | 2015 | 2349 | 0.070 |
Why?
|
Maternal-Fetal Exchange | 1 | 2008 | 461 | 0.070 |
Why?
|
Malonyl Coenzyme A | 1 | 2006 | 19 | 0.070 |
Why?
|
Pancreatectomy | 2 | 2014 | 811 | 0.070 |
Why?
|
Transcription, Genetic | 5 | 2010 | 7571 | 0.070 |
Why?
|
Mice, Obese | 1 | 2007 | 418 | 0.070 |
Why?
|
Aging | 4 | 2013 | 8702 | 0.070 |
Why?
|
Vanadates | 2 | 1995 | 82 | 0.070 |
Why?
|
Receptor, IGF Type 1 | 1 | 2008 | 380 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2017 | 1935 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5321 | 0.060 |
Why?
|
Hormones | 1 | 2010 | 868 | 0.060 |
Why?
|
Cytoskeleton | 1 | 2011 | 1169 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 613 | 0.060 |
Why?
|
Thermogenesis | 1 | 2010 | 477 | 0.060 |
Why?
|
Cognition | 1 | 2023 | 6988 | 0.060 |
Why?
|
Diazoxide | 1 | 2005 | 52 | 0.060 |
Why?
|
Carboxy-Lyases | 1 | 2006 | 85 | 0.060 |
Why?
|
Body Composition | 2 | 2015 | 2427 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 614 | 0.060 |
Why?
|
Biopsy | 2 | 2011 | 6781 | 0.060 |
Why?
|
3T3-L1 Cells | 1 | 2006 | 208 | 0.060 |
Why?
|
Proteomics | 1 | 2019 | 3840 | 0.060 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 790 | 0.060 |
Why?
|
Thyrotropin | 1 | 2009 | 833 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2455 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 56 | 0.060 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 342 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 5 | 2009 | 17897 | 0.060 |
Why?
|
Octreotide | 1 | 2005 | 154 | 0.060 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 103 | 0.060 |
Why?
|
Sweetening Agents | 1 | 2007 | 290 | 0.060 |
Why?
|
Diet Therapy | 1 | 2005 | 151 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2015 | 5871 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39127 | 0.060 |
Why?
|
Glucose Transporter Type 4 | 1 | 2004 | 240 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1663 | 0.060 |
Why?
|
Prevalence | 2 | 2019 | 15721 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 26072 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4027 | 0.060 |
Why?
|
Nuclear Respiratory Factors | 1 | 2003 | 18 | 0.060 |
Why?
|
Fibroblasts | 1 | 2014 | 4138 | 0.060 |
Why?
|
Heart | 2 | 2015 | 4431 | 0.060 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2003 | 21 | 0.060 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 2003 | 23 | 0.060 |
Why?
|
Prognosis | 2 | 2024 | 29688 | 0.050 |
Why?
|
Actins | 1 | 2011 | 2046 | 0.050 |
Why?
|
Litter Size | 1 | 2023 | 49 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16954 | 0.050 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 917 | 0.050 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2009 | 855 | 0.050 |
Why?
|
Glycogen Synthase | 2 | 2000 | 62 | 0.050 |
Why?
|
Progeria | 1 | 2005 | 188 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 436 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13386 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1126 | 0.050 |
Why?
|
Histone Deacetylases | 1 | 2007 | 717 | 0.050 |
Why?
|
Pregnancy, Animal | 1 | 2003 | 124 | 0.050 |
Why?
|
Lipid Peroxidation | 1 | 2003 | 271 | 0.050 |
Why?
|
Mexican Americans | 1 | 2003 | 164 | 0.050 |
Why?
|
Hyperplasia | 1 | 2005 | 1150 | 0.050 |
Why?
|
Regeneration | 1 | 2011 | 1505 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2010 | 15841 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1656 | 0.050 |
Why?
|
Glycolysis | 2 | 2003 | 836 | 0.050 |
Why?
|
Cholesterol, HDL | 2 | 2005 | 1812 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8002 | 0.050 |
Why?
|
Food, Formulated | 1 | 2001 | 101 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1613 | 0.050 |
Why?
|
Protein Kinases | 2 | 2006 | 1607 | 0.050 |
Why?
|
Extracellular Fluid | 1 | 2022 | 165 | 0.050 |
Why?
|
Fetus | 1 | 2008 | 1864 | 0.050 |
Why?
|
ras Proteins | 1 | 2006 | 1055 | 0.040 |
Why?
|
Trinucleotide Repeats | 1 | 2001 | 257 | 0.040 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2001 | 375 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1056 | 0.040 |
Why?
|
Vanadium Compounds | 1 | 2000 | 8 | 0.040 |
Why?
|
Adipose Tissue, White | 1 | 2023 | 362 | 0.040 |
Why?
|
Rats, Wistar | 2 | 2005 | 1848 | 0.040 |
Why?
|
Proteins | 3 | 2003 | 5993 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1749 | 0.040 |
Why?
|
Pyrazoles | 1 | 2010 | 2010 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2021 | 265 | 0.040 |
Why?
|
Blood Vessels | 1 | 2005 | 1111 | 0.040 |
Why?
|
Adipocytes, Brown | 2 | 2011 | 151 | 0.040 |
Why?
|
Myasthenia Gravis | 1 | 2002 | 214 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1998 | 489 | 0.040 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 1997 | 433 | 0.040 |
Why?
|
Myocardium | 2 | 2015 | 4746 | 0.040 |
Why?
|
Myositis | 1 | 2002 | 270 | 0.040 |
Why?
|
Gluconeogenesis | 2 | 2011 | 185 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2022 | 563 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2004 | 1149 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3821 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 360 | 0.040 |
Why?
|
Phosphotransferases | 1 | 1999 | 303 | 0.040 |
Why?
|
Polyenes | 1 | 1998 | 68 | 0.040 |
Why?
|
Time Factors | 3 | 2010 | 39957 | 0.040 |
Why?
|
Endocrinology | 1 | 2024 | 442 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4479 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3702 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2515 | 0.040 |
Why?
|
Ursodeoxycholic Acid | 1 | 2017 | 81 | 0.040 |
Why?
|
Seizures | 1 | 2010 | 2965 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4567 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 1999 | 3446 | 0.040 |
Why?
|
Tyrosine | 2 | 1999 | 1422 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12052 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2021 | 4513 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2006 | 4420 | 0.030 |
Why?
|
Inflammation | 1 | 2016 | 10759 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2392 | 0.030 |
Why?
|
Androstadienes | 1 | 1998 | 348 | 0.030 |
Why?
|
Glycosylation | 1 | 1999 | 1095 | 0.030 |
Why?
|
Incidence | 2 | 2007 | 21366 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2023 | 2974 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 1168 | 0.030 |
Why?
|
Substrate Specificity | 1 | 1999 | 1768 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2004 | 2058 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2002 | 1891 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15920 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2001 | 1234 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1240 | 0.030 |
Why?
|
Epilepsy | 1 | 2010 | 3304 | 0.030 |
Why?
|
Flavonoids | 1 | 1998 | 444 | 0.030 |
Why?
|
Adolescent | 5 | 2024 | 88300 | 0.030 |
Why?
|
Protein Isoforms | 1 | 1999 | 1695 | 0.030 |
Why?
|
Huntington Disease | 1 | 2001 | 1145 | 0.030 |
Why?
|
Osteoporosis | 1 | 2024 | 1604 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15308 | 0.030 |
Why?
|
Computational Biology | 1 | 2006 | 3499 | 0.030 |
Why?
|
Testis | 2 | 2013 | 781 | 0.030 |
Why?
|
Threonine | 1 | 2015 | 270 | 0.030 |
Why?
|
Oxygen Consumption | 2 | 2011 | 1867 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1666 | 0.030 |
Why?
|
Carnitine | 1 | 2015 | 252 | 0.030 |
Why?
|
Disease Progression | 2 | 2009 | 13511 | 0.030 |
Why?
|
Mitochondria, Heart | 1 | 2015 | 229 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58952 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1194 | 0.030 |
Why?
|
Organ Specificity | 1 | 1998 | 1963 | 0.030 |
Why?
|
Genomics | 1 | 2009 | 5829 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6200 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 2014 | 329 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2003 | 2640 | 0.030 |
Why?
|
Phosphotyrosine | 3 | 1999 | 455 | 0.020 |
Why?
|
Pancreatic Diseases | 1 | 2014 | 345 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2015 | 748 | 0.020 |
Why?
|
Placentation | 1 | 2012 | 78 | 0.020 |
Why?
|
Diet | 2 | 2010 | 8048 | 0.020 |
Why?
|
Vasodilation | 2 | 2006 | 966 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2014 | 942 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 30004 | 0.020 |
Why?
|
Finland | 1 | 2012 | 607 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14610 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2011 | 452 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2418 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 486 | 0.020 |
Why?
|
Cell Division | 1 | 1998 | 4451 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 370 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 10756 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1737 | 0.020 |
Why?
|
Acclimatization | 1 | 2010 | 113 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 173 | 0.020 |
Why?
|
Biological Transport | 2 | 2006 | 2081 | 0.020 |
Why?
|
Molecular Weight | 2 | 2005 | 2171 | 0.020 |
Why?
|
Glucose Clamp Technique | 2 | 2000 | 262 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2010 | 182 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 135 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 130 | 0.020 |
Why?
|
Chromans | 1 | 2008 | 117 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3073 | 0.020 |
Why?
|
Syndrome | 1 | 2015 | 3271 | 0.020 |
Why?
|
Young Adult | 3 | 2024 | 59222 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 801 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3603 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54437 | 0.020 |
Why?
|
Myoblasts | 1 | 2008 | 231 | 0.020 |
Why?
|
Pancreatitis | 1 | 2014 | 1081 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3907 | 0.020 |
Why?
|
Embryonic Development | 1 | 2012 | 719 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2002 | 3163 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2406 | 0.020 |
Why?
|
Drug Implants | 1 | 2007 | 230 | 0.020 |
Why?
|
Captopril | 1 | 2007 | 262 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 2008 | 567 | 0.020 |
Why?
|
Child | 4 | 2019 | 80154 | 0.020 |
Why?
|
Lipoprotein Lipase | 1 | 2006 | 133 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2002 | 4251 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4243 | 0.020 |
Why?
|
Deoxyglucose | 1 | 2006 | 333 | 0.020 |
Why?
|
Peroxisomes | 1 | 2006 | 68 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2007 | 1159 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2009 | 767 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 42225 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10553 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2014 | 3210 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1668 | 0.010 |
Why?
|
Creatine Kinase | 1 | 2006 | 684 | 0.010 |
Why?
|
Brachial Artery | 1 | 2005 | 366 | 0.010 |
Why?
|
Temperature | 1 | 2010 | 2219 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1741 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2706 | 0.010 |
Why?
|
Glucosidases | 1 | 2002 | 12 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5032 | 0.010 |
Why?
|
Electron Transport Complex III | 1 | 2002 | 31 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 501 | 0.010 |
Why?
|
Electron Transport Complex II | 1 | 2002 | 53 | 0.010 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2002 | 53 | 0.010 |
Why?
|
Genes | 1 | 2006 | 1820 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2007 | 1202 | 0.010 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2002 | 94 | 0.010 |
Why?
|
Streptozocin | 1 | 2002 | 193 | 0.010 |
Why?
|
Rats, Long-Evans | 1 | 2003 | 380 | 0.010 |
Why?
|
Electron Transport Complex IV | 1 | 2002 | 190 | 0.010 |
Why?
|
Procollagen | 1 | 2002 | 187 | 0.010 |
Why?
|
Succinate Dehydrogenase | 1 | 2002 | 145 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6125 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1743 | 0.010 |
Why?
|
Electron Transport Complex I | 1 | 2002 | 153 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2005 | 720 | 0.010 |
Why?
|
Models, Biological | 2 | 2010 | 9458 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2006 | 2340 | 0.010 |
Why?
|
Orchiectomy | 1 | 2003 | 463 | 0.010 |
Why?
|
Ovariectomy | 1 | 2003 | 614 | 0.010 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2000 | 45 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 1067 | 0.010 |
Why?
|
Liver Diseases | 1 | 2009 | 1301 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2003 | 1762 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2113 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1504 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2002 | 411 | 0.010 |
Why?
|
Lipoproteins | 1 | 2005 | 877 | 0.010 |
Why?
|
United States | 2 | 2024 | 72341 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4921 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 551 | 0.010 |
Why?
|
Anaerobic Threshold | 1 | 1999 | 51 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2006 | 1360 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2003 | 1030 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 665 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2015 | 5775 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2002 | 833 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2000 | 456 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1997 | 174 | 0.010 |
Why?
|
Cell Membrane | 1 | 2007 | 3661 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2091 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2001 | 747 | 0.010 |
Why?
|
RNA | 1 | 2007 | 2709 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2005 | 7851 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3691 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4246 | 0.010 |
Why?
|
Collagen | 1 | 2005 | 2635 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2002 | 1318 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 24022 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2005 | 2380 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11067 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5773 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2217 | 0.010 |
Why?
|
Coronary Disease | 1 | 2009 | 5921 | 0.010 |
Why?
|
Leg | 1 | 1999 | 1087 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 36415 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 475 | 0.010 |
Why?
|
Internet | 1 | 2006 | 3096 | 0.010 |
Why?
|
Heart Diseases | 1 | 2006 | 2795 | 0.010 |
Why?
|
Software | 1 | 2006 | 4431 | 0.010 |
Why?
|
Ultrasonography | 1 | 2005 | 5969 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7386 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2005 | 3407 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1995 | 2426 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8164 | 0.000 |
Why?
|